Thomas A. Olson

Emory University — United States

Medicine · Health Sciences

35h-index3.7kcitations154works4.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Testicular diseases and treatments(61), Sarcoma Diagnosis and Treatment(36), Neuroblastoma Research and Treatments(33), Ovarian cancer diagnosis and treatment(12), Glioma Diagnosis and Treatment(9)

Publications153 total

Outcome of Children With Intermediate‐Risk Extracranial Malignant Germ Cell Tumors by Response Status at the End of Induction Chemotherapy: A Report From the Children's Oncology Group
Pediatric Blood & Cancer·2025
Multicenter Retrospective Analysis of Pediatric Differentiated Thyroid Carcinoma: Treatment Practices and Outcomes Prior to Pediatric American Thyroid Association Guidelines Implementation
Pediatric Blood & Cancer·2025· 1 cited
Treatment Outcomes and Definition Inconsistencies in High-Risk Unilateral Retinoblastoma
American Journal of Ophthalmology·2024· 2 cited
HIGH-RISK HISTOPATHOLOGICAL FEATURES OF RETINOBLASTOMA FOLLOWING PRIMARY ENUCLEATION
Retina·2024· 6 citedOpen Access
Abstract 6379: Comparison of lipid profiles in children with solid tumors receiving chemotherapy and healthy children
Cancer Research·2024
Multi-omics analysis of the gut microbiome and metabolites associated with the psychoneurological symptom cluster in children with cancer receiving chemotherapy
Journal of Translational Medicine·2024· 8 citedOpen Access
Consensus and controversy in the management of paediatric and adult patients with ovarian immature teratoma: the Malignant Germ Cell International Consortium perspective
EClinicalMedicine·2024· 16 citedOpen Access
P615: Low rate of clinical follow-up for potential germline variants identified in hematologic malignancies with a next generation sequencing panel
Genetics in Medicine Open·2024Open Access
Abstract 6731: Gut microbiome associated with the psychoneurological symptom cluster among children with solid tumors receiving chemotherapy
Cancer Research·2023
Addressing the diagnostic and therapeutic dilemmas of ovarian immature teratoma: Report from a clinicopathologic consensus conference
European Journal of Cancer·2022· 15 cited
Abstract 720: Comparison of the gut microbiome between children with solid tumor receiving chemotherapy and healthy children
Cancer Research·2022· 1 cited
Outcomes of patients with unilateral retinoblastoma: A report from the RIVERBOAT Consortium.
Journal of Clinical Oncology·2022
Outcomes of patients with bilateral retinoblastoma: A report from the RIVERBOAT Consortium.
Journal of Clinical Oncology·2022
How to Maintain a Healthy Gut Microbiome in Children with Cancer? Gut Microbiome Association with Diet in Children with Solid Tumors Postchemotherapy
OMICS A Journal of Integrative Biology·2022· 5 citedOpen Access
Germ Cell Tumors of the Head and Neck
Pediatric oncology·2022
Rare Tumors: A Different Perspective on Oncology
Pediatric oncology·2022· 2 cited
Tumors of Unknown Primary Site
Pediatric oncology·2022
Mediastinal Germ Cell Tumors
Pediatric oncology·2022
Gonadal and Extragonadal Germ Cell Tumors, Sex Cord Stromal and Rare Gonadal Tumors
Pediatric oncology·2022· 3 cited
Intraventricular topotecan in the successful treatment of recurrent CNS pleuropulmonary blastoma
Pediatric Blood & Cancer·2021
page 1 of 8Next →

Frequent Co-authors

Deborah F. Billmire(14), A. Lindsay Frazier(14), Mark Krailo(11), Carlos Rodríguez‐Galindo(10), Farzana Pashankar(10), Frederick J. Rescorla(9), James F. Amatruda(9), Furqan Shaikh(9), John W. Cullen(8), Wendy B. London(7), Stephen J. Lauer(7), Sara Stoneham(7), Marcio H. Malogolowkin(7), Barbara Cushing(6), Roger Giller(6), Neyssa Marina(6), Mary M. Davis(6), Juliet Hale(6), Matthew J. Murray(6), James C. Nicholson(6)